David Patrick Kateete
Overview
Explore the profile of David Patrick Kateete including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lekuya H, Vandersteene J, Kateete D, Makumbi F, Cose S, Kalala J, et al.
Epilepsia
. 2025 Feb;
PMID: 39982418
Objective: This study aimed to identify perioperative clinical and radiological factors that predict the risk of developing late posttraumatic seizures (PTS) within 24 months of injury among surgically managed traumatic...
2.
Enterococcus and Eggerthella species are enriched in the gut microbiomes of COVID-19 cases in Uganda
Agudelo C, Kateete D, Nasinghe E, Kamulegeya R, Lubega C, Mbabazi M, et al.
Gut Pathog
. 2025 Feb;
17(1):9.
PMID: 39905557
Background: Infection with the COVID-19-causing pathogen SARS-CoV-2 is associated with disruption in the human gut microbiome. The gut microbiome enables protection against diverse pathogens and exhibits dysbiosis during infectious and...
3.
Lekuya H, Cose S, Nakibuule M, Ahimbisibwe G, Fuller A, Kamabu L, et al.
Front Neurol
. 2025 Jan;
15:1484742.
PMID: 39744105
Background: The safe timing window for surgery during the acute phase of inflammation due to traumatic brain injury (TBI) has not been studied extensively. We aimed to elucidate the relationship...
4.
Babirye S, Nsubuga M, Mboowa G, Batte C, Galiwango R, Kateete D
BMC Infect Dis
. 2024 Dec;
24(1):1391.
PMID: 39639222
Background: Efforts toward tuberculosis management and control are challenged by the emergence of Mycobacterium tuberculosis (MTB) resistance to existing anti-TB drugs. This study aimed to explore the potential of machine...
5.
Ssekamatte P, Nabatanzi R, Sitenda D, Nakibuule M, Bagaya B, Kibirige D, et al.
Front Immunol
. 2024 Oct;
15:1480739.
PMID: 39430752
Background: Efforts to eradicate tuberculosis (TB) are threatened by diabetes mellitus (DM), which confers a 3-fold increase in the risk of TB disease. The changes in the memory phenotypes and...
6.
Lekuya H, Vandersteene J, Kamabu L, Nantambi R, Mbiine R, Kirabira A, et al.
Neurotrauma Rep
. 2024 Oct;
5(1):824-844.
PMID: 39391048
Surgical site infections (SSIs) remain a major cause of life-threatening morbidity following surgery for depressed skull fractures (DSFs) among patients with traumatic brain injury (TBI). The timing of the surgery...
7.
Bwanga F, Mukashyaka C, Kateete D, Tumuhamye J, Okeng A, Aboce E, et al.
BMC Microbiol
. 2024 Aug;
24(1):307.
PMID: 39155368
Background: Staphylococcus aureus (S. aureus) often colonizes the human skin, upper respiratory and genital tracts. In the female genital tract, it can be passed on to the newborn during vaginal...
8.
Lekuya H, Kateete D, Olweny G, Kigozi E, Kamabu L, Mudekereza S, et al.
PLoS One
. 2024 Jul;
19(7):e0303483.
PMID: 39047022
Background: Surgical site infections (SSI) are a significant concern following traumatic brain injury (TBI) surgery and often stem from the skin's microbiota near the surgical site, allowing bacteria to penetrate...
9.
Nshimiyimana T, Najjuka C, Nalwanga W, Katende G, Kateete D
Afr Health Sci
. 2024 Jul;
23(4):216-229.
PMID: 38974281
In 2013, Uganda introduced the PCV10 pneumococcal vaccine and it is given to children at 6, 10 and 14 weeks after birth. Carriage prevalence studies post PCV10-introduction are necessary for...
10.
Kayongo A, Ntayi M, Olweny G, Kyalo E, Ndawula J, Ssengooba W, et al.
iScience
. 2024 Jun;
27(6):110142.
PMID: 38904070
remains one of the deadliest infectious agents globally. Amidst efforts to control TB, long treatment duration, drug toxicity, and resistance underscore the need for novel therapeutic strategies. Despite advances in...